Shareholders' Deficit (Details) - Schedule of Activity Related to Non-Vested Shares |
9 Months Ended |
---|---|
Sep. 30, 2023
$ / shares
shares
| |
Schedule of Activity Related to Non-Vested Shares [Abstract] | |
Number of Non-Vested Shares, beginning balance | shares | 16,970,120 |
Weighted Average Grant Date Fair Value, beginning balance | $ / shares | $ 0.119 |
Number of Non-Vested Shares, Granted | shares | |
Weighted Average Grant Date Fair Value, Granted | $ / shares | |
Number of Non-Vested Shares, Shares vested | shares | (2,000,000) |
Weighted Average Grant Date Fair Value, Shares vested | $ / shares | $ 0.021 |
Number of Non-Vested Shares, ending balance | shares | 14,970,120 |
Weighted Average Grant Date Fair Value, ending balance | $ / shares | $ 0.132 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Number of options vested. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|